|
|
|
|
Scientific Program
Program Description
Statement of Need
According to the American Cancer Society, nearly 175,000 Americans will learn they have lung cancer this year. More Americans die each year from lung cancer than from breast, prostate and colorectal cancers combined (www.lungcancer.org).
Surgery, chemotherapy and radiation therapy are typically used to treat lung cancer. A multidisciplinary meeting will promote interaction between these discipline in order to achieve the best possible outcome for the patient. This model will also bring together physician specialists from around the world for interdisciplinary discussions on the latest research and state-of-the-art care for thoracic cancers.
Learning Objectives
- Report current standards of care in thoracic cancers.
- Identify current novel therapies and agents currently under investigation in thoracic malignancies.
- Describe and discuss the role of multimodality therapy in thoracic cancers.
- Investigate the latest advances in the management of thoracic cancers.
- Explore supportive outcomes.
Target Audience
The meeting is designed for radiation, medical, and surgical oncologists, nurses, scientists, residents-in-training, and other healthcare professionals interested in the treatment, screening, evaluation and management of thoracic cancers.
Continuing Medical Education
Accreditation Statement
The American Society for Therapeutic Radiology and Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
PHYSICIANS
Credit Designation
The American Society for Therapeutic Radiology and Oncology (ASTRO) designates this educational activity for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
TECHNOLOGISTS
Application has been made to ASRT for designation of Category A continuing education credit.
DOSIMETRISTS
Application has been made to the Medical Dosimetrist Certification Board.
NURSES
The Oncology Nursing Society (ONS) is accredited as an approver of continuing education for nurses by the American Nurses Credentialing Center’s Commission on Accreditation. Application has been to ONS for CEU credits.
PHYSICISTS
Application has been made to the Commission on Accreditation of Medical Physics Education Program for CAMPEP Credit.
Disclosure of Vested Interest
Presenters will disclose any vested interest or their intention to discuss off-label use of pharmaceuticals or devices, if applicable, to the audience at the beginning of their presentation and in accordance with ACCME standards and FDA requirements.
Schedule of Events
Schedule as of 4/28/08
WEDNESDAY, NOVEMBER 12, 2008 |
| 3:00 p.m.. - 7:00 p.m. |
Registration |
THURSDAY, NOVEMBER 13, 2008 |
7:00 a.m. - 8:00 a.m. |
Registration and Continental Breakfast
|
| 8:00 a.m. - 8:05 a.m. |
Welcome and Program Overview |
Everett E. Vokes, M.D.
University of Chicago Medical Center |
| 8:05 a.m. - 8:30 a.m. |
General Session I
Keynote Lecture 1
Critical Progress in the Treatment of Lung Cancer |
Introduction:
Everett E. Vokes, M.D.
University of Chicago Medical Center
Paul A. Bunn, Jr., M.D.
University of Colorado Cancer Center |
| 8:30 a.m. - 10:00 a.m. |
General Session II
High Tech Therapies |
Moderators:
Jeffrey A. Bogart, M.D.
SUNY Upstate Medical University
Jeffrey D. Bradley, M.D.
Washington University Medical School
Presenters:
David A. Bush, M.D.
Loma Linda University School of Medicine
TBA |
| 10:00 a.m. - 10:15 a.m. |
Break in Exhibit Hall |
| 10:15 a.m. - 11:15 a.m. |
Oral Abstract Session I
(Possible Concurrent Session) |
Moderators:
Walter J. Curran, M.D. FACR
Emory University School of Medicine
Philip Bonomi, M.D.
Rush University Medical Center
|
| 11:15 a.m. - 12:15 p.m. |
General Session III
Outcome Measures and Quality of Life
|
Moderator:
Benjamin Movsas, M.D.
Henry Ford Hospital
Presenters:
Jeff A. Sloan, Ph.D.
Mayo Clinic
Susan A. Yount, Ph.D.
Northwestern University |
| 12:15 p.m. - 1:15 p.m. |
Lunch |
| 1:15 p.m. - 2:15 p.m. |
General Session IV
Mesothelioma
(Interactive) |
Moderator:
Harvey I. Pass, M.D.
New York University
Presenters:
Michele Carbonne, M.D., Ph.D.
University of Hawaii
Hedy L. Kindler, M.D.
University of Chicago
Craig W. Stevens, M.D., Ph.D.
H. Lee Moffitt Cancer Center
|
| 2:15 p.m. - 3:45 p.m. |
General Session V
Challenges in New Drug Development-Imaging and Biomarkers |
Moderator:
David Gandara M.D.
University of California Davis
Presenters:
John V. Heymach, M.D.
M. D. Anderson Cancer Center
Anthony F. Shields, M.D., Ph.D.
Hudson-Weber Cancer Research Center
TBA
|
| 3:45 p.m. - 4:00 p.m. |
Break in Exhibit Hall |
| 4:00 p.m. - 5:00 p.m. |
General Session VI
Experimental Therapeutics A: EGFR |
Moderator:
Fred R. Hirsch, M.D., Ph.D.
University of Colorado Cancer Center
Presenters:
Ramaswamy Govindan, M.D.
Washington University
Pasi Janne, M.D.
Dana Farber Cancer Institute
Frances Shepherd, M.D.
Princess Margaret Hospital
|
| 5:00 p.m. - 5:45 p.m. |
General Session VII
Case Presentations – Small Cell Lung Cancer
(Interactive)
|
Moderators:
Lawrence B. Marks, M.D.
Duke University
Sarita Dubey, M.D.
University of California San Francisco |
| 5:45 p.m. - 6:30 p.m. |
General Poster Session and Reception |
FRIDAY, NOVEMBER 14, 2008 |
| 7:00 a.m. - 8:00 a.m. |
Registration and Continental Breakfast |
| 8:00 a.m. - 8:30 a.m. |
General Session VIII
Keynote Lecture 2:
Surveying Signaling Networks: A New View of Cancer |
Introduction:
Everett E. Vokes, M.D.
University of Chicago Medical Center
Michael J . Comb, Ph.D.
Cell Signaling Technology, Inc.
|
| 8:30 a.m. - 10:00 a.m. |
General Session IX
Experimental Therapeutics B: Early Novel Targets |
Moderator:
Ravi Salgia, M.D., Ph.D.
University of Chicago
Presenters:
Charles Rudin, M.D., Ph.D.
Johns Hopkins University
Jerry Shay, Ph.D.
University of Texas Southwestern
TBA
|
| 10:00 a.m. - 10:30 a.m. |
Break in Exhibit Hall |
10:30 a.m. - 12:00 p.m. |
General Session X
Personalized Chemotherapy |
Moderator:
Corey J. Langer, M.D.
Fox Chase Cancer Center
Presenters:
Gerold Bepler, M.D., Ph.D.
H. Lee Moffitt Cancer Center
David Gandara, M.D.
University of California Davis Cancer Center
George R. Simon, M.D.
H. Lee Moffitt Cancer Center
TBA
|
| 12:00 p.m. - 12:30 p.m. |
Oral Abstract Session
(possible concurrent session) |
Moderators:
TBA |
| 12:30 p.m. - 1:30 p.m. |
Lunch |
| 12:30 p.m. - 1:30 p.m. |
Medical Jeopardy Lunch -- Teams comprised of residents and fellows by university.
Attendees can attend, first-come, first-served basis |
| 1:30 pm - 2:30 pm |
General Session XI
Staging of Lung Cancer
(Interactive)
|
Moderator:
Frank C. Detterbeck, M.D., FACS
Yale University
Presenters:
TBA
|
| 2:30 p.m. - 3:30 p.m. |
General Session XII
Brain Metastases |
Moderators:
Ritsuko U. Komaki , M.D.
M.D. Anderson Cancer Center
Masahiro Hiraoka, M.D.,
Kyoto University
Presenters:
Minesh Mehta, M.D.
University of Wisconsin
Hiroki Shirato, M.D.
Hokkaido University
James Welsh, M.D.
University of Arizona |
| 3:30 p.m. - 4:00 p.m. |
Break in Exhibit Hall
|
| 4:00 p.m. - 4:30 p.m. |
General Session XIII
The Pros &Cons of Screening for Lung Cancer
|
Moderator:
James R. Jett, M.D.
Mayo Clinic
Presenters:
Avrum Spira, M.D.
Boston University |
| 4:30 p.m. - 5:45 p.m. |
General Session XIV
Hot Topics 1: Maintenance Therapy |
Moderator:
Wilfried Eberhardt, M.D. University of Essen Medical School
Mark A. Socinski, M.D.
University of North Carolina
Presenters:
Tudor Ciulaneu, M.D.
Cluj-Napoca, Romania
TBA
|
| 5:45 p.m. - 6:30 p.m. |
General Poster Session and Reception |
| SATURDAY, NOVEMBER 15, 2008 |
| 7:00 a.m. - 8:00 a.m. |
Registration and Continental Breakfast
|
| 8:00 a.m. - 9:00 a.m. |
General Session XV
Outcome Measures: Imaging |
Moderator:
Michael MacManus, M.D.
Peter MacCallum Cancer Institute
Presenters:
Feng Kong, M.D.
University of Michigan
Quynh-Thu Le, M.D.
Stanford University
Jean Paul Sculier, M.D.
Institut Jules Bordet
Johan Vansteenskiste, M.D.
University Hospital Gasthuisberg
|
| 9:00 a.m. - 10:00 a.m. |
General Session XVI
Surgical Issues in Lung Cancer |
Moderator:
Kemp H. Kernstine M.D., Ph.D.
City of Hope National Medical Center
Presenters:
Kathy S. Albain, M.D.
Loyola University
David M. Jablons, M.D.
University of California San Francisco
William Warren, M.D.
Rush University Medial Center |
| 10:00 a.m. - 10:15 a.m. |
Break |
10:15 a.m. - 11:30a.m. |
General Session XVII
Hot Topics 2: Immunotherapy and Prevention |
Moderator:
Stephen M. Hahn, M.D.
University of Pennsylvania
Presenters:
Frances A. Shepherd, M.D.
Princess Margaret Hospital
James L. Mulshine, M.D.
Rush University Medical Center
TBA |
| 11:30a.m. - 12:30 p.m. |
General Session XVIII
Experimental Therapeutics C: Angiogenesis & Cox-2 |
Moderator:
Katherine M.W. Pisters, M.D.
MD Anderson Cancer Center
Presenters:
Steven M. Dubinett, M.D.
David Geffen School of Medicine at UCLA
David H. Johnson, M.D.
Vanderbilt University |
| 12:30 p.m. |
Meeting Concludes |
Steering Committee
Everett E. Vokes, M.D., Chair
University of Chicago Medical Center
|
David Gandara, M.D.
University of California Davis
Cancer Center
IASLC Representative |
Kathy S. Albain, M.D.
Loyola University |
Karen Kelly, M.D.
The University of Kansas Medical Center
ASCO Representative |
Paul A. Bunn, Jr., M.D.
University of Colorado Cancer Center |
Ritsuko U. Komaki, M.D.
M.D. Anderson Cancer Center
ASTRO Representative |
Program Committee
Stephen M. Hahn, M.D.,
Chair
University of Pennsylvania |
Ravi Salgia, M.D.
Chair-Elect
University of Chicago |
Christine B. Ambrosone, Ph.D.
Roswell Park Cancer Institute |
Kemp Kerstine, M.D.
City of Hope National Medical Center |
Jeffrey A. Bogart, M.D.
SUNY Upstate Medical Center |
Corey Langer, M.D.
Fox Chase Cancer Center
|
Phillip A. Bonomi, M.D.
Rush Medical College
|
Robert B. Love, M.D.
Loyola University |
| Jeffrey D. Bradley, M.D.
Washington University Medical School |
Michael MacManus, M.D.
Peter MacCallum Cancer Institute |
John J. Crowley, Ph.D.
University of Washington |
Lawrence B. Marks, M.D.
Duke University |
Wilfried Eberhardt, M.D.
University of Essen Medical School |
York E. Miller, M.D.
Denver Veterans Administration Medical Center |
Masahiro Hiraoka, M.D., Ph.D.
Kyoto University, Japan |
Benjamin Movsas, M.D.
Henry Ford Hospital |
Fred H. Hirsch, M.D., Ph.D.
University of Colorado Cancer Center |
James L. Mulshine, M.D.
Rush Medical College |
Pasi Janne, M.D.
Dana Farber Cancer Institute |
Harvey I. Pass, M.D.
New York University |
James R. Jett, M.D.
Mayo Clinic |
Katherine M. W. Pisters, M.D.
M.D. Anderson Cancer Center
|
Frances A. Shepherd, M.D.
Princess Margaret Hospital |
|
 |
|
|
|
|
|
